PHAR logo

Pharming Group NV (PHAR) Interest Expense

Annual Interest Expense

$5.96 M
+$606.00 K+11.31%

31 December 2023

1-Year Change

+11.31%
PHAR annual interest expense is up +11.31% year-on-year

3-Year Change

+0.34%
PHAR annual interest expense is up +0.34% over the past 3 years

All-time High

$22.38 M
PHAR annual interest expense is currently -73.35% below its historical high of $22.38 million

Sector Rank

59.25%
PHAR annual interest expense is higher than 59.25% of companies in Healthcare sector
Annual Interest Coverage Ratio-1.01
PHAR annual interest coverage ratio is -1.01
Annual Total Expenses$267.32 M
PHAR annual total expenses is $267.32 million
Annual Operating Expenses$242.11 M
PHAR annual total operating expenses is $242.11 million
Annual Cost Of Goods Sold$25.21 M
PHAR annual cost of goods sold is $25.21 million

PHAR Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

$3.00 M
+$1.02 M+51.87%

30 September 2024

3-Year Change

+127.12%
PHAR quarterly interest expense is up +127.12% over the past 3 years

All-time High

$16.97 M
PHAR quarterly interest expense is currently -82.33% below its historical high of $16.97 million

Sector Rank

64.16%
PHAR quarterly interest expense is higher than 64.16% of companies in Healthcare sector
Quarterly Interest Coverage Ratio1.51
PHAR quarterly interest coverage ratio is 1.51
Quarterly Total Expenses$70.74 M
PHAR quarterly total expenses is $70.74 million
Quarterly Operating Expenses$63.92 M
PHAR quarterly total operating expenses is $63.92 million
Quarterly Cost Of Goods Sold$6.82 M
PHAR quarterly cost of goods sold is $6.82 million

PHAR Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

$7.87 M
+$3.00 M+61.52%

30 September 2024

3-Year Change

+171.18%
PHAR TTM interest expense is up +171.18% over the past 3 years

All-time High

$25.95 M
PHAR TTM interest expense is currently -69.67% below its historical high of $25.95 million

Sector Rank

59.07%
PHAR TTM interest expense is higher than 59.07% of companies in Healthcare sector
Annual Interest Coverage Ratio-1.01
PHAR annual interest coverage ratio is -1.01
Annual Total Expenses$267.32 M
PHAR annual total expenses is $267.32 million
Annual Operating Expenses$242.11 M
PHAR annual total operating expenses is $242.11 million
TTM Cost Of Goods Sold$30.30 M
PHAR TTM cost of goods sold is $30.30 million

PHAR TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PHAR Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.3%--
3 y3 years+0.3%+127.1%+171.2%
5 y5 years-63.6%-48.6%-26.1%

PHAR Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-2.1%+11.3%at high+1623.0%at high+171.2%
5 y5 years-63.6%+11.3%-76.5%+119.3%-63.4%+171.2%
alltimeall time-73.3%+2702.6%-82.3%+114.2%-69.7%+138.0%

Pharming Group NV Interest Expense History

DateAnnualQuarterlyTTM
Sept 2024
-
$3.00 M(+51.9%)
$7.87 M(+61.5%)
June 2024
-
$1.97 M(+26.9%)
$4.87 M(+58.6%)
Mar 2024
-
$1.56 M(+15.9%)
$3.07 M(-28.7%)
Dec 2023
$5.96 M(+11.3%)
$1.34 M(+671.8%)
$4.31 M(-23.0%)
June 2023
-
$174.00 K(-93.8%)
$5.60 M(-17.4%)
Mar 2023
-
$2.79 M(+102.5%)
$6.77 M(+26.4%)
Dec 2022
$5.36 M(-12.0%)
$1.38 M(+10.5%)
$5.36 M(-4.4%)
Sept 2022
-
$1.25 M(-7.5%)
$5.60 M(-1.3%)
June 2022
-
$1.35 M(-2.1%)
$5.67 M(-3.4%)
Mar 2022
-
$1.38 M(-15.1%)
$5.87 M(-3.6%)
Dec 2021
$6.09 M(+2.5%)
$1.63 M(+23.1%)
$6.09 M(-155.1%)
Sept 2021
-
$1.32 M(-14.7%)
-$11.06 M(-2980.3%)
June 2021
-
$1.55 M(-3.1%)
$383.90 K(-150.7%)
Mar 2021
-
$1.60 M(-110.3%)
-$757.60 K(-112.7%)
Dec 2020
$5.94 M(-55.5%)
-$15.52 M(-221.6%)
$5.94 M(-72.4%)
Sept 2020
-
$12.76 M(+3039.4%)
$21.53 M(+47.5%)
June 2020
-
$406.50 K(-95.1%)
$14.60 M(-21.7%)
Mar 2020
-
$8.30 M(>+9900.0%)
$18.65 M(+39.7%)
Dec 2019
$13.35 M(-18.4%)
$64.00 K(-98.9%)
$13.35 M(+25.3%)
Sept 2019
-
$5.83 M(+30.9%)
$10.66 M(-35.4%)
June 2019
-
$4.46 M(+48.4%)
$16.50 M(+37.0%)
Mar 2019
-
$3.00 M(-214.1%)
$12.05 M(+33.2%)
Dec 2018
$16.37 M(-26.8%)
-$2.63 M(-122.5%)
$9.04 M(-22.5%)
Sept 2018
-
$11.68 M
$11.68 M
Dec 2017
$22.38 M(+493.1%)
-
-
Dec 2016
$3.77 M(+284.2%)
-
-
DateAnnualQuarterlyTTM
Dec 2015
$981.80 K(+361.4%)
-
-
Dec 2014
$212.80 K(-95.4%)
-
-
Dec 2013
$4.66 M(+35.8%)
-$6.14 M(-424.4%)
$4.66 M(-5.9%)
Sept 2013
-
$1.89 M(-53.3%)
$4.96 M(-15.6%)
June 2013
-
$4.05 M(-16.6%)
$5.87 M(+9.1%)
Mar 2013
-
$4.86 M(-183.2%)
$5.38 M(+56.9%)
Dec 2012
$3.43 M(+1143.0%)
-$5.84 M(-308.1%)
$3.43 M(-62.5%)
Sept 2012
-
$2.81 M(-21.2%)
$9.15 M(+41.6%)
June 2012
-
$3.56 M(+22.6%)
$6.46 M(+114.8%)
Mar 2012
-
$2.91 M(-2458.3%)
$3.01 M(+989.4%)
Dec 2011
$276.10 K(-76.0%)
-$123.20 K(-205.3%)
$276.10 K(-101.3%)
Sept 2011
-
$117.00 K(+7.7%)
-$20.72 M(-0.0%)
June 2011
-
$108.60 K(-37.5%)
-$20.73 M(+435.8%)
Mar 2011
-
$173.70 K(-100.8%)
-$3.87 M(+223.4%)
Dec 2010
$1.15 M(-90.3%)
-$21.12 M(<-9900.0%)
-$1.20 M(-105.1%)
Sept 2010
-
$107.70 K(-99.4%)
$23.33 M(-10.1%)
June 2010
-
$16.97 M(+496.2%)
$25.95 M(+114.5%)
Mar 2010
-
$2.85 M(-16.4%)
$12.10 M(+4.0%)
Dec 2009
$11.87 M(-10.3%)
$3.40 M(+24.7%)
$11.63 M(+41.4%)
Sept 2009
-
$2.73 M(-12.4%)
$8.22 M(+49.7%)
June 2009
-
$3.12 M(+31.0%)
$5.49 M(+131.0%)
Mar 2009
-
$2.38 M
$2.38 M
Dec 2008
$13.23 M(+683.8%)
-
-
Dec 2007
$1.69 M(-1.2%)
-
-
Dec 2006
$1.71 M(+112.5%)
-
-
Dec 2005
$804.20 K
-
-

FAQ

  • What is Pharming Group NV annual interest expense?
  • What is the all time high annual interest expense for Pharming Group NV?
  • What is Pharming Group NV annual interest expense year-on-year change?
  • What is Pharming Group NV quarterly interest expense?
  • What is the all time high quarterly interest expense for Pharming Group NV?
  • What is Pharming Group NV TTM interest expense?
  • What is the all time high TTM interest expense for Pharming Group NV?

What is Pharming Group NV annual interest expense?

The current annual interest expense of PHAR is $5.96 M

What is the all time high annual interest expense for Pharming Group NV?

Pharming Group NV all-time high annual interest expense is $22.38 M

What is Pharming Group NV annual interest expense year-on-year change?

Over the past year, PHAR annual interest expense has changed by +$606.00 K (+11.31%)

What is Pharming Group NV quarterly interest expense?

The current quarterly interest expense of PHAR is $3.00 M

What is the all time high quarterly interest expense for Pharming Group NV?

Pharming Group NV all-time high quarterly interest expense is $16.97 M

What is Pharming Group NV TTM interest expense?

The current TTM interest expense of PHAR is $7.87 M

What is the all time high TTM interest expense for Pharming Group NV?

Pharming Group NV all-time high TTM interest expense is $25.95 M